Literature DB >> 30814104

Uncommon presentation of medication-related osteonecrosis of the mandible in a patient with metastatic prostate cancer.

Meera Thavarajah1, Rahul Jayaram1.   

Abstract

An 82-year-old man with a background of prostate carcinoma and bony metastases presented with bilateral discharging neck fistulae. Two years prior to presentation, the patient had been treated with intravenous zoledronic acid for 1 year as part of chemotherapy. Intraoral examination revealed extensive bilateral medication-related osteonecrosis, with orocutaneous fistulae within the neck. Treatment comprised removal of loose necrotic bone sequestrae, debridement of the fistulae and long-term administration of antibiotics, vitamin E and pentoxifylline. Four weeks later, the orocutaneous fistulae had healed. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  dentistry and oral medicine; mouth; oncology; prostate cancer

Mesh:

Substances:

Year:  2019        PMID: 30814104      PMCID: PMC6398671          DOI: 10.1136/bcr-2018-228238

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Infection and medication-related osteonecrosis of the jaw.

Authors:  H Katsarelis; N P Shah; D K Dhariwal; M Pazianas
Journal:  J Dent Res       Date:  2015-02-20       Impact factor: 6.116

2.  MRONJ risk reduction pathway - 360 degree survey.

Authors:  A Muthukrishnan; S Al-Ismail; G Bertelli; P Browne
Journal:  Br Dent J       Date:  2017-03-10       Impact factor: 1.626

Review 3.  [Osteonecrosis of the jaws (ONJ) associated to antiresorptive treatment].

Authors:  Cecilia Larsson Wexell; Anders Kjellman; Olof Akre
Journal:  Lakartidningen       Date:  2018-05-25

4.  Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

Authors:  Robert E Marx; Yoh Sawatari; Michel Fortin; Vishtasb Broumand
Journal:  J Oral Maxillofac Surg       Date:  2005-11       Impact factor: 1.895

5.  Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series.

Authors:  Adepitan A Owosho; Cherry L Estilo; Joseph M Huryn; SaeHee K Yom
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-07-13

Review 6.  The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.

Authors:  Thomas B Dodson
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2015-09-09       Impact factor: 2.802

Review 7.  The role of dental care providers in the management of patients prescribed bisphosphonates: brief clinical guidance.

Authors:  Hassan H Abed; Elham N Al-Sahafi
Journal:  Gen Dent       Date:  2018 May-Jun

8.  Recommendations for the Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw: A Systematic Review.

Authors:  Flávia Aparecida Cariolatto; Julia Carelli; Taís de Campos Moreira; Ricardo Pietrobon; Clarissa Rodrigues; Ana Paula Bonilauri Ferreira
Journal:  J Evid Based Dent Pract       Date:  2017-12-02       Impact factor: 5.267

9.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

10.  Bisphosphonates and osteonecrosis of the jaw: a case report.

Authors:  André Borba Reiriz; Patrícia de Moraes De Zorzi; Cristian Patrik Lovat
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.